Ma Jiayang
Transaction: 09/25/2024
OTHER
Change
0
Price
Not reported
Filing
01/31/2025
Type
OTHER
Longduoduo Company Limited
LDDD • Medical - Diagnostics & Research
$0.51
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$15.31M
Growth
218.5%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 10.8%Positive revenue growth · 218.5%Positive free cash flow · 0.01Consistent free cash flow · 4/5Manageable debt level · 0.02
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Mar 31, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.51
Change0.00%
Shares Out30.02M
Market Cap$15.31M
Enterprise Value$14.15M
52W Range0.51 - 4.99
Beta0.36
P/E-43.42
P/S7.18
P/B20.77
P/FCF-48.76
EV/Sales6.64
Price$0.51
Change0.00%
Shares Out30.02M
Market Cap$15.31M
Enterprise Value$14.15M
52W Range0.51 - 4.99
Beta0.36
P/E-43.42
P/S7.18
P/B20.77
P/FCF-48.76
EV/Sales6.64
EV/EBITDA-50.52
EV/FCF-45.07
Earnings Yield-2.30%
FCF Yield-2.05%
Dividend Yield0.00%
Gross Margin97.86%
Oper. Margin12.97%
Profit Margin10.80%
Debt/Eq0.02
Current Ratio2.18
Quick Ratio2.18
Revenue 5Y218.55%
FCF 5Y66.93%
Volume374.00
Avg Volume3.00
Investment DNA
How strong this company looks for long-term investors
65
out of 100
Business Quality
Margins, moat, returns
71/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Stable or improving margins · 10.8%Positive revenue growth · 218.5%Positive free cash flow · 0.01Consistent free cash flow · 4/5Manageable debt level · 0.02Healthy liquidity · 2.18
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Shan Bo
Transaction: 11/27/2023
OTHER
Change
0
Price
Not reported
Filing
12/27/2023
Type
OTHER
Xu Huibo
Transaction: 11/27/2023
OTHER
Change
0
Price
Not reported
Filing
12/13/2023
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Ma Jiayang | OTHER | 0 | Not reported | 09/25/2024 | 01/31/2025 |
| Shan Bo | OTHER | 0 | Not reported | 11/27/2023 | 12/27/2023 |
| Xu Huibo | OTHER | 0 | Not reported | 11/27/2023 | 12/13/2023 |
| Liping Kang | SELL | 0 | Not reported | 11/27/2023 | 12/11/2023 |
| Hongxiao Zhou | OTHER | 0 | Not reported | 11/27/2023 | 12/11/2023 |
| Zhang Liang | SELL | 0 | Not reported | 11/27/2023 | 12/11/2023 |
| Li Zhijie | OTHER | 0 | Not reported | 11/27/2023 | 12/11/2023 |
| Wu Binbin | OTHER | 0 | Not reported | 11/27/2023 | 12/11/2023 |